Metropolis Healthcare transfers EQAS division to subsidiary for ₹1.25 crore
- Metropolis Healthcare transferred its EQAS Division to subsidiary MQSPL
- The slump sale consideration was ₹1.25 crore
- Payment was made via issuance of MQSPL equity shares
- The transfer became effective on August 27, 2026
- Operations are now carried out by the subsidiary as a going concern
*this image is generated using AI for illustrative purposes only.
Metropolis Healthcare Ltd transferred its External Quality Assessment Services Business Division to a wholly owned subsidiary effective August 27, 2026. The transaction was executed as a slump sale for a consideration of ₹1.25 crore.
Metropolis Healthcare completed the transfer of the EQAS Division to Metropolis Quality Solutions Private Limited (MQSPL). The company discharged the consideration by issuing equity shares of MQSPL to itself, in accordance with the terms of the Business Transfer Agreement.
Transaction Details
The transfer was structured as a going concern. Effective August 27, 2026, all operations relating to the EQAS Division are carried out by MQSPL.
| Parameter | Detail |
|---|---|
| Division Transferred | External Quality Assessment Services Business Division |
| Transferee | Metropolis Quality Solutions Private Limited |
| Consideration | ₹1.25 crore |
| Payment Mode | Issuance of equity shares of MQSPL |
| Effective Date | August 27, 2026 |
Regulatory Disclosure
The company made this disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This filing follows earlier intimations dated February 4, 2026, and August 4, 2026.
Kamlesh C Kulkarni, Head – Legal & Secretarial, confirmed the transaction in the communication to BSE Limited and National Stock Exchange of India Limited.
Historical Stock Returns for Metropolis Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.16% | +3.95% | +1.17% | +22.06% | +6.84% | -14.15% |
How will the separation of the EQAS division into MQSPL impact Metropolis Healthcare's consolidated revenue and EBITDA margins in upcoming fiscal quarters?
Does this restructuring signal a strategic intent to spin off or list Metropolis Quality Solutions Private Limited (MQSPL) as an independent entity in the future?
What are the potential tax implications or regulatory hurdles associated with structuring this transfer as a slump sale under Indian corporate law?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
